Du, Yong
Coughlin, Jennifer M.
Brosnan, Mary Katherine
Chen, Allen
Shinehouse, Laura K.
Abdallah, Rehab
Lodge, Martin A.
Mathews, William B.
Liu, Chen
Wu, Yunkou
Minn, Il
Finley, Paige
Hall, Andrew W.
Lesniak, Wojciech G.
Dannals, Robert F.
Horti, Andrew G.
Pomper, Martin G. http://orcid.org/0000-0001-6753-3010
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (EB024495)
National Center for Advancing Translational Sciences (UL1TR001079)
Article History
Received: 3 January 2023
Accepted: 18 February 2023
First Online: 6 March 2023
Declarations
:
: This study was approved by the Johns Hopkins Institutional Review Board and was conducted under a FDA-approved US investigational new drug application (IND 131367). All experimental animal protocols were performed in accordance with relevant federal and state laws and institutional guidelines and approved by the Animal Care and Use Committee of the Johns Hopkins Medical Institutions.
: Written, informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.